# FDA Inspection 627926 - Biomat USA, Inc. - November 13, 2009

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a785de99-a1dd-44c4-9cff-8d42524a3d4c
Source feed: FDA_Inspections

> FDA Inspection 627926 for Biomat USA, Inc. on November 13, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 627926
- Company Name: Biomat USA, Inc.
- Inspection Date: 2009-11-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1220702 - 2023-08-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d2a10cf3-3250-4c0f-9e3e-d50466068aa3)
- [FDA Inspection 1220702 - 2023-08-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/47376061-3b60-4533-bed9-2f62ee2ea73c)
- [FDA Inspection 1028285 - 2017-09-14](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c7037bb7-6b6f-4093-8fba-dc5df090468c)
- [FDA Inspection 938626 - 2015-07-22](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4eb6fd3d-6017-4d9c-9538-c54802df8f50)
- [FDA Inspection 865387 - 2014-01-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/28eb1dda-b25c-4415-a3e8-d780ea4acff0)

Company: https://www.keypedia.com/companies/biomat-usa-inc/88b3327f-0598-4bf4-a111-e892b5929f9e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d